Global Nicergoline Market Research Report 2024

Nicergoline is an ergot derivative indicated to treat senile dementia and vascular disorders such as cerebral thrombosis, Raynaud's disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy. It is also indicated for migraines of vascular origin, coadjutant therapy in clinical situations, corio-retinal vascular disorders, oto-vestibular problems. It is sold under the brand name Sermion among others. Nicergoline is a potent vasodilator that helps improve brain blood flow by decreases vascular resistance and improving the utilization of glucose and oxygen by brain cells.

The global Nicergoline market was valued at US$ 885 million in 2023 and is anticipated to reach US$ 2354.7 million by 2030, witnessing a CAGR of 16.6% during the forecast period 2024-2030.

The global nicergoline market is projected to grow steadily. The rising burden of vascular disorders worldwide will drive the demand for Nicergoline. Rising incidences of complications due to vascular disorders are anticipated to drive the demand for Nicergoline. Increasing prevalence of cerebral thrombosis, Raynaud's disease, vascular migraines, atherosclerosis, arterial blockages in the limbs, and retinopathy are projected to raise volume calls for Nicergoline. Growing FDA approval for new disease treatments is foreseen to create new growth opportunities. However, the availability of other substitutes in the market is likely to restrain the market growth. Specific challenges are roaming around the market. Adverse events have been noted associated with allergic or hypersensitivity-type reactions after the Nicergoline injection into the body. This may hinder the market growth.

This report aims to provide a comprehensive presentation of the global market for Nicergoline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicergoline.

Report Scope

The Nicergoline market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicergoline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nicergoline manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation


By Company


Teva API

FAREVA

Olon Group

Hainan Poly Pharm Co. Ltd

DEAFARMA

Solarium Pharmaceuticals

Fengchen

LGC

Pfizer Pharmaceutical Co., Ltd.

Hebei Lingding Biotechnology Co., Ltd.

Selleck Chemicals

Tocris Bioscience

Kunshan Rotam Reddy Pharmaceutical Co. Ltd.

Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.

Shandong Fangming Pharmaceutical Group Co. Ltd.

Hainan General Kangli Pharmaceutical Co. Ltd.

Hainan Zambon Pharmaceutical Co. Ltd

Pharmacia

Shandong Qidu Pharmaceutical Co. Ltd.


Segment by Type


For Injection

For Oral


Segment by Application


Alzheimer's Disease (AD)

Arterial Hypertension

Cerebral Thrombosis

Others


Consumption by Region


North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Nicergoline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Nicergoline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.